The study shows even middle aged men need advice about

July 6, 2010 by Johnson Anders · Leave a Comment
Filed under: Drug 

The study shows that even middle-aged men need advice about spreading and catching STDs, especially AIDS, which is deadly and incurable, Dr. Anupam Jena of Harvard Medical School in Boston and colleagues wrote.
Users of ED erectile dysfunction drugs had higher rates of HIV, chlamydia, gonorrhea and syphilis in the 12 months before filling their first [...]

New medications likely hit hardest under tough pricing

July 2, 2010 by Philbert Ross · Leave a Comment
Filed under: Drug 

The report comes as governments across Europe are seeking to slash drugs prices as they reign in spending to try to tackle runaway budget deficits.
Germanys government approved a draft bill on Tuesday which aims to eventually save some 2 billion euros 2.4 billion each year on the cost of patented drugs by breaking up drugmakers [...]

A report european school management and technology

July 1, 2010 by Johnson Anders · Leave a Comment
Filed under: Drug 

New medications likely to be hit hardest under tough pricing regulation include antibiotics, as well as treatments for heart disease and immune system disorders such as multiple sclerosis and chronic meningitis, it said.
The report comes as governments across Europe are seeking to slash drugs prices as they reign in spending to try to tackle runaway [...]

While industry observers widely believed astrazeneca

June 30, 2010 by Editor · Leave a Comment
Filed under: Drug 

Judge Joseph Farnan, of the U.S. District Court in Delaware, ruled that generic drugmakers who challenged the patent failed to prove it was invalid because it was an obvious invention.
Farnan also ruled that defendants have not established, by clear and convincing evidence, that the 314 patent is invalid as an improper reissue of an older [...]

The conflicting results were released on monday

June 29, 2010 by Editor · Leave a Comment
Filed under: Drug 

The medicine was Glaxos second-biggest drug but is much smaller after a safety controversy erupted three years ago.
One analysis of 56 clinical trials found Avandia increased the chances of a heart attack by 28 percent to 39 percent, researchers at the Cleveland Clinic in Ohio said in an update to a 2007 study that [...]

The european medicines agency said its committee

June 26, 2010 by Editor · Leave a Comment
Filed under: Drug 

The study, known as a meta-analysis and published by U.S. researchers earlier this month, looked at all the publicly available data and found that patients were 1.2 percent more likely to be diagnosed with a new cancer over four years than people who did not take the drugs.
The CHMP will review the meta-analysis thoroughly, together [...]

Mylotarg won approval under abbreviated process help bring

June 22, 2010 by Editor · Leave a Comment
Filed under: Drug 

Medicines cleared in that way must pass follow-up tests to confirm they work.
The Food and Drug Administration said on Monday it asked Pfizer to withdraw the drug after a recent clinical trial raised new concerns about the products safety and the drug failed to demonstrate clinical benefit to patients enrolled in trials.
Mylotargs first-quarter sales [...]

Exelixis said on sunday it will continue to develop drug

June 21, 2010 by Aleccia Yule · Leave a Comment
Filed under: Drug 

We have the resources to take this forward for some time, Exelixis Chief Executive George Scangos told Reuters, noting that the company may seek another partnership.
Under a deal signed in late 2008, Bristol-Myers had paid Exelixis 240 million for the rights to XL184 and another drug, called XL281a 195 million upfront cash payment, plus additional [...]

German drugmaker boehringer ingelheim failed convince

June 19, 2010 by Philbert Ross · Leave a Comment
Filed under: Drug 

The efficacy was not sufficiently robust to justify the risks, said Dr. Julia Johnson, the panels chairwoman and head of obstetrics and gynecology at the University of Massachusetts Medical School.
Women reported depression, fainting, fatigue and other problems in company studies of the drug known chemically as flibanserin.
The once-a-day pill, taken at bedtime, is the latest [...]

Emergency department visits involving nonmedical use pain

June 18, 2010 by Editor · Leave a Comment
Filed under: Drug 

We urgently need to take action, CDC Director Dr. Thomas Frieden said in a statement, noting that trips to the emergency department for nonmedical use of prescription pain drugs are now as common as those for use of illicit drugs.
These prescriptions medicines help many people, but we need to be sure they are used properly [...]

Next Page »